Why the Ramsay Health Care Limited (ASX:RHC) share price was crushed today

In addition to worries over private health affordability in Australia, Ramsay Health Care Limited (ASX:RHC) is facing tough market conditions overseas.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Ramsay Health Care Limited (ASX: RHC) plunged 8% to $57.28 on Thursday, after the company gave a disappointing update about its operations in Australia and the UK.

Ramsay announced that a review of the carrying value of UK assets, necessary to comply with accounting standards, will lead to a charge of £70 million (about $125 million) net of tax in onerous lease provisions and asset write-downs.

The charge applies to six of its UK facilities – out of 35 that Ramsay owns – with the Berkshire Independent and Ashtead hospitals accounting for 85% of the impairment.

The company specified that these are non-cash items and will have no impact on debt facilities or compliance with financial covenants. The goodwill of the UK business will also remain unaffected.

Managing Director Craig McNally said that while the last tariff adjustment by the UK National Health Service (NHS) and a public health care funding boost announced this week by Prime Minister Theresa May were good news for the company, NHS demand management strategies were weighing on patients volumes, despite the increasing number of people awaiting treatment.

As conditions in the UK are expected to remain challenging in the medium term, the company will work on improving operational efficiency and strengthening its operations with privately insured patients.

Impairments on UK assets will be excluded from the company's FY18 core net profit after tax and won't have an impact on dividends.

Ramsay also flagged difficulties with its Australian operations. Waning in-patient volume growth and delays in the launch of Ramsay's pharmacy franchise induced the company to downgrade its core EPS growth forecast to 7%, compared to the previous guidance of 8% to 10%.

Given the current climate around private health insurance and affordability, this trend is expected to continue into FY19, and the company is investigating opportunities to grow through acquisition.

Based on the revised figure, the stock is currently trading at 20x FY18's estimated core earnings, which isn't cheap given its weakening short-term prospects.

Foolish takeway

Despite its limited impact on Ramsay's financial performance, this update reinforces the worries for the near future that have weighed down the stock in the past year.

As demographic trends in Australia and overseas clearly point towards a progressively ageing population and increasing demand for medical treatment, I still think Ramsay is a good long-term investment, but I wouldn't be surprised to see its share price weaken in the coming months.

However, there are other blue chip stocks poised to outperform in 2018. Click here to get your free report and find out more.

Motley Fool contributor Tommaso Autorino has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »